advertisement
11.3.4 Betablocker (12)
Showing records 1 to 12
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker12710 Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients
Nieminen T; Uusitalo H; Turjanmaa V; Bjarnhall G; Hedenstrom H; Maenpaa J; Ropo A; Heikkila P; Kahonen M
European Journal of Clinical Pharmacology 2005; 61: 369-374
12598 Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension
Craven ER; Walters TR; Williams R; Chou C; Cheetham JK; Schiffman R
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 337-348
13001 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension
Goni FJ; Brimonidine/Timolol Fixed Combination Study Group
European Journal of Ophthalmology 2005; 15: 581-590
12600 Effects of a non-selective β-blocker on adult rat anterograde axonal transport and retinal ganglion layer after increased intraocular pressure
Diaz F; Villena A; Moreno M; Vidal L; Parrado C; Garcia Campos J; Perez de Vargas I
Histology and Histopathology 2005; 20: 1077-1084
12601 Polymorphism of the β-2 adrenoceptor and IOP lowering potency of topical timolol in healthy subjects
Fuchsjager Mayrl G; Markovic O; Losert D; Lucas-T; Wachek V; Muller M; Schmetterer L
Molecular Vision 2005; 11: 811-815
13213 A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or
Hughes BA; Bacharach J; Craven ER; Kaback MB; Mallick S; Landry TA; Bergamini MV
Journal of Glaucoma 2005; 14: 392-399
13118 Comparative study on the combined effects of bunazosin and nipradilol or timolol on intraocular pressure in normotensive rabbits
Orihashi M; Shima Y; Tsuneki H; Kimura I
Japanese Journal of Ophthalmology 2005; 49: 523-526
13032 Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients
Renard P; Kovalski JL; Cochereau I; Jaulerry S; Williamson W; Elena PP; Lablache Combier M; Allaire C; Siou-Mermet R
Graefe's Archive for Clinical and Experimental Ophthalmology 2005; 243: 1221-1227
13145 β1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers
Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
Ophthalmology 2005; 112: 2131-2136
13182 Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel
Uusitalo H; Nino J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kahonen M
Acta Ophthalmologica Scandinavica 2005; 83: 723-728
12602 The efficacy of timolol in gel-forming solution after morning or evening dosing in Asian glaucomatous patients
Ong LB; Liza Sharmini AT; Chieng LL; Cheong MT; Vengadasalam SR; Shin HC; Balaravi P
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 388-394
13223 Clinical investigation: the intraocular pressure lowering efficacy and safety of brinzolamide combined with betaxolol
Yu M; Fang M; Ge J; Huang S
Eye Science 2005; 21: 137-140
